Stockscreener 앱 받기
4.09
1.92%
-0.08
전일 마감가:
$4.17
열려 있는:
$3.98
하루 거래량:
23,170
Relative Volume:
0.23
시가총액:
$78.31M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.89%
1개월 성능:
-25.50%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$3.86
$4.17
1주일 범위
$3.86
$4.3262
52주 변동 폭
$3.63
$5.50
Basel Medical Group Ltd Stock (BMGL) Company Profile
BMGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMGL
Basel Medical Group Ltd
|
4.09 | 78.31M | 0 | 0 | 0 | 0.00 |
|
HCA
Hca Healthcare Inc
|
349.69 | 81.74B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.93 | 14.71B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
EHC
Encompass Health Corp
|
117.20 | 11.64B | 5.22B | 422.40M | 269.50M | 4.14 |
|
THC
Tenet Healthcare Corp
|
150.82 | 11.51B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
179.66 | 11.27B | 15.42B | 1.03B | 956.84M | 15.02 |
Basel Medical Group Ltd 주식(BMGL)의 최신 뉴스
Basel Medical Group Completes Acquisition of Bethesda Medical - TipRanks
Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - The Manila Times
Basel Medical Group Ltd Completes Acquisition of Bethesda Medical Pte. Ltd. to Strengthen Presence in Singapore Healthcare Market - Nasdaq
Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - GlobeNewswire Inc.
Maples Group advises Basel Medical on NASDAQ IPO - ICLG.com
Basel Medical Group announces leadership shake-up By Investing.com - Investing.com Nigeria
Basel Medical Group announces leadership shake-up - Investing.com Australia
Basel Medical Group Announces Leadership Changes in April 2025 - TipRanks
Basel Medical Group Ltd -Resignation Of Raymond Cheung As Chief Executive Officer - marketscreener.com
WORK Medical Technology Group receives Nasdaq notification - Medical Buyer
Basel Medical Group acquires Bethesda Medical - Medical Buyer
SEA Digest: Basel to buy SG's Bethesda Medical; Indonesia's Surge bags NTT East investment - DealStreetAsia
Bethesda Medical acquired by Basel Medical - Crunchbase
Basel Medical to acquire Bethesda Medical, terms undisclosed - TipRanks
Basel Medical Group Expands with Acquisition of Bethesda Medical - TipRanks
Basel Medical Group to Acquire Bethesda Medical in Southeast Asia Expansion Push - marketscreener.com
Basel Medical to buy Singapore-based Bethesda Medical - Seeking Alpha
Basel Medical To Acquire Singapore's Bethesda Medical For Undisclosed Terms - Nasdaq
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - The Manila Times
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pre-market Movers: VERO, WORX, GFR, ALTG, QLGN… - RTTNews
Basel Medical Group Appoints Founder Raymond Fung to Board - TipRanks
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - PR Newswire
Oscar-winning Palestinian director ‘attacked by Israeli settlers and detained’ - North Wales Chronicle
Palestinian Director of 'No Other Land' Attacked by Settler Mob, Arrested by Soldiers, Israeli Co-director Says - Haaretz
Basel Medical Group Completes Overallotment Option Exercise in IPO - TipRanks
Basel Medical Group Ltd Announces Exercise of Overallotment Option - The Manila Times
Orchid Island Capital Announces March 2025 Monthly Dividend and February 28, 2025 RMBS Portfolio Characteristics - The Manila Times
Basel Medical Group Ltd Completes Full Exercise of Overallotment Option in IPO, Raising Additional $1.32 Million - Nasdaq
Novartis is watching US reciprocal tariff policy 'very carefully', CEO says - Reuters
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - TradingView
Roche secures Zealand obesity drug candidate for up to $5.3 billion - Reuters
Med-tech sector starts strong, with $6.28B in 2025 financings - BioWorld MedTech
Kestra Medical stock surges on public debut (KMTS:NASDAQ) - Seeking Alpha
Basel Medical prices $8.8M IPO - BioWorld Online
Basel Medical Group Ltd Completes $8.82 Million IPO - TipRanks
Mahindra Launches two Electric Origin SUVs, the BE 6 & the XEV 9e for India, Available with Monroe Intelligent Suspension Technology - The Manila Times
Basel Medical Group Ltd Closes $8.82 Million Initial Public Offering on Nasdaq - Nasdaq
Basel Medical Group Closes $8.8 Million IPO - marketscreener.com
Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies - Yahoo Finance
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline - Seeking Alpha
Basel Medical Group Ltd Launches $8.82 Million IPO on Nasdaq - TipRanks
Basel Medical Group stock edges up 4% following U.S. IPO - MSN
Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down - Nasdaq
Basel Medical Group Prices US $8,820,000 Initial Public Offering - TradingView
Basel Medical prices IPO of over 2 million shares at $4.00 per share - Investing.com India
Why Basel Medical Group Ltd (NASDAQ:BMGL) Looks Like A Quality Company - Yahoo Finance
Basel Medical Prices IPO at $4.00-$5.00 Per Share (BMGL) - Defense World
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study | Eye - Nature
Roche Group's total sales 2006-2024 - Statista
Basel Medical Group Ltd (BMGL) 재무 분석
Basel Medical Group Ltd (BMGL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.21%
0.46%
자본화:
|
볼륨(24시간):